Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Altamir Amboise (ALMP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
26.30 -0.30    -1.13%
11:24:00 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  France
ISIN:  FR0000053837 
  • Volume: 722
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 26.20 - 26.80
Altamir 26.30 -0.30 -1.13%

Altamir Amboise Company Profile

 
Get an in-depth profile of Altamir Amboise, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryInvestment Banking & Investment Services
SectorFinancials
Employees

-

Equity Type

ORD

Altamir SCA, formerly known as Altamir Amboise, is a private equity investment arm of Amboise SAS, specializing in both direct and fund of fund investments, small and mid-cap companies. In direct investing, the firm specializes in middle market, buyout and growth capital investments. The firm prefers to invest in under-developed divisions of larger corporations. It prefers to invest in private equity funds specializing in growth capital and leverage buyouts investments from Europe, United States and Canada. The firm typically invests in the following sectors: healthcare, TMT, digital companies, consumer services, education services, retail and distribution. It also invests in retail and consumer, business and financial services. In healthcare, it seeks to focus on companies with strong growth potential in areas such as health services (hospitalization structures, home health care and medical analysis); medical devices; in niche pharmaceutical laboratories; and companies in related activities such as dermo-cosmetics, galenic development, and services and databases for health organizations. The firm seeks to invest in unlisted companies based in Europe, with a particular focus on Belgium, France, Luxembourg, Switzerland, Monaco, Italy, Netherlands, Germany and French-speaking Europe; United States and Canada and in larger emerging markets such as China, India and Brazil. In small and mid-cap companies firm prefers to invest in Continental Europe with a focus in France, Italy and Benelux, & larger size companies in Europe, North America and emerging countries like China, India and Brazil. In small and mid-cap size companies it prefers to invest with enterprise value between €50 million ($55.36 million) and €500 million ($553.6 million) and in larger size companies it prefers to invest with enterprise value between €500 million ($553.60 million) and €3000 million ($3321.62 million). It invests in funds that seek to have a majority stake in its investments or be a lead shareholder. It invests and disinvests with the private equity funds of Apax Partners France and Amboise Investissement under the same conditions and also invests directly in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm seeks to exit its investments within five years. It makes balance sheet investments. Altamir SCA was founded in 1995 and is based in Paris, France.

Contact Information

Address 1 rue Paul Cézanne
Paris, 75008
France
Phone 33 1 53 65 01 00
Fax -

Top Executives

Name Age Since Title
Maurice Tchenio 80 - Chairman & CEO
Marleen Groen 67 2014 Independent Member of Supervisory Board
Dominique Cerutti 62 2021 Independent Member of Supervisory Board
Jean Estin 73 2018 Independent Chairman of Supervisory Board
Anne Landon 64 2019 Independent Member of Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALMP Comments

Write your thoughts about Altamir Amboise
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email